In particular, miR-576-5p influences multiple pathways implied in NAFLD, including mammalian target of rapamycin (mTOR), a kinase modulated by insulin that induces hepatic lipogenesis through a PPARγ-dependent mechanism [72]. The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatotic liver disease.